MMP2 Polymorphisms and Colorectal Cancer Susceptibility in a Chinese Han Population

References

• Sung H, Ferlay J, Siegel RL. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Thanikachalam K, Khan G. Colorectal cancer and nutrition. Nutrients. 2019;11:164. doi:10.3390/nu11010164
   PubMed Web of Science ®Google Scholar
• Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021;35:787–820. doi:10.1101/gad.348226.120
   PubMed Web of Science ®Google Scholar
• Bhullar DS, Barriuso J, Mullamitha S, Saunders MP, O’Dwyer ST, Aziz O. Biomarker concordance between primary colorectal cancer and its metastases. EBioMedicine. 2019;40:363–374. doi:10.1016/j.ebiom.2019.01.050
   PubMed Web of Science ®Google Scholar
• Skrede OJ, De Raedt S, Kleppe A, et al. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet. 2020;395:350–360. doi:10.1016/S0140-6736(19)32998-8
   PubMed Web of Science ®Google Scholar
• Choi CK, Shin MH, Cho SH, et al. Association between ALDH2 and ADH1B polymorphisms and the risk for colorectal cancer in Koreans. Cancer Res Treat. 2021;53:754–762. doi:10.4143/crt.2020.478
   PubMed Web of Science ®Google Scholar
• Guo X, Lin W, Wen W, et al. Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects. Gastroenterology. 2021;160:1164–1178.e1166. doi:10.1053/j.gastro.2020.08.062
   PubMed Web of Science ®Google Scholar
• He Y, Timofeeva M, Zhang X. Colorectal cancer risk variants rs10161980 and rs7495132 are associated with cancer survival outcome by a recessive mode of inheritance. Int J Cancer. 2021;148:2774–2778. doi:10.1002/ijc.33465
   PubMed Web of Science ®Google Scholar
• Pittayapruek P, Meephansan J, Prapapan O, Komine M, Ohtsuki M. Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int J Mol Sci. 2016;17:868–887. doi:10.3390/ijms17060868
   PubMed Web of Science ®Google Scholar
• Han Y, Ma L, Zhao L, Feng W, Zheng X. Rosmarinic inhibits cell proliferation, invasion and migration via up-regulating miR-506 and suppressing MMP2/16 expression in pancreatic cancer. Biomed Pharmacother. 2019;115:108878–108886. doi:10.1016/j.biopha.2019.108878
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang Z, Chen J, Xue M, Pan X. ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer. Int J Biol Sci. 2021;17:3048–3058. doi:10.7150/ijbs.62293
   PubMed Web of Science ®Google Scholar
• Tian Y, An F, Wang J, et al. MMP2 and MMP10 polymorphisms are related to steroid-induced osteonecrosis of the femoral head among Chinese Han population. Biomed Res Int. 2019;2019:8298193. doi:10.1155/2019/8298193
   PubMed Web of Science ®Google Scholar
• Ou YX, Bi R. Meta-analysis on the relationship between the SNP of MMP-2-1306 C>T and susceptibility to breast cancer. Eur Rev Med Pharmacol Sci. 2020;24:1264–1270. doi:10.26355/eurrev_202002_20181
   PubMed Web of Science ®Google Scholar
• Qaseem A, Crandall CJ, Mustafa RA, et al. Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians. Ann Intern Med. 2019;171:643–654. doi:10.7326/M19-0642
   PubMed Web of Science ®Google Scholar
• Gholamalizadeh M, Akbari ME, Doaei S, et al. The association of fat-mass-and obesity-associated gene polymorphism (rs9939609) with colorectal cancer: a case-control study. Front Oncol. 2021;11:732515. doi:10.3389/fonc.2021.732515
   PubMed Web of Science ®Google Scholar
• Semlali A, Almutairi MH, Alamri A, Reddy Parine N. Expression and polymorphism of TSLP/TSLP receptors as potential diagnostic markers of colorectal cancer progression. Genes. 2021;12:1386. doi:10.3390/genes12091386
   PubMed Web of Science ®Google Scholar
• Li H, Liu Y, Liu J, et al. Assessment of ADCY9 polymorphisms and colorectal cancer risk in the Chinese Han population. J Gene Med. 2021;23:e3298. doi:10.1002/jgm.3298
   PubMed Web of Science ®Google Scholar
• Du Z, Tang CH, Li LJ, et al. Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese. Int J Med Sci. 2020;17:97–102. doi:10.7150/ijms.37675
   PubMed Web of Science ®Google Scholar
• Wang N, Zhou S, Fang XC, et al. MMP-2, −3 and TIMP-2, −3 polymorphisms in colorectal cancer in a Chinese Han population: a case-control study. Gene. 2020;730:144320. doi:10.1016/j.gene.2019.144320
   PubMed Web of Science ®Google Scholar
• Banday MZ, Sameer AS, Mir AH, Mokhdomi TA, Chowdri NA, Haq E. Matrix metalloproteinase (MMP) −2, −7 and −9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review. Gene. 2016;589:81–89. doi:10.1016/j.gene.2016.05.028
   PubMed Web of Science ®Google Scholar
• McColgan P, Sharma P. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer. 2009;125:1473–1478. doi:10.1002/ijc.24441
   PubMed Web of Science ®Google Scholar
• Scherer D, Deutelmoser H, Balavarca Y, Toth R. Polymorphisms in the angiogenesis-related genes EFNB2, MMP2 and JAG1 are associated with survival of colorectal cancer patients. Int J Mol Sci. 2020;21:5359. doi:10.3390/ijms21155395
   PubMed Web of Science ®Google Scholar
• Liu D, Kang H, Gao M, Jin L, Zhang F, Chen D. Exosome-transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2. Mol Oncol. 2020;14:1365–1380. doi:10.1002/1878-0261.12637
   PubMed Web of Science ®Google Scholar
• Tryggvason K, Höyhtyä M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat. 1993;24:209–218. doi:10.1007/BF01833261
   PubMed Web of Science ®Google Scholar
• Huang GL, Chen QX, Ma JJ, Sui SY, Wang YN, Shen DY. Retinoic acid receptor α facilitates human colorectal cancer progression via Akt and MMP2 signaling. Onco Targets Ther. 2019;12:3087–3098. doi:10.2147/OTT.S200261
   PubMed Web of Science ®Google Scholar
• Lu K, Dong J, Fan W. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer. Eur Rev Med Pharmacol Sci. 2018;22:8210–8219. doi:10.26355/eurrev_201812_16514
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44:D877–881. doi:10.1093/nar/gkv1340
   PubMed Web of Science ®Google Scholar
• Karambataki M, Malousi A, Kouidou S. Risk-associated coding synonymous SNPs in type 2 diabetes and neurodegenerative diseases: genetic silence and the underrated association with splicing regulation and epigenetics. Mutat Res. 2014;770:85–93. doi:10.1016/j.mrfmmm.2014.09.005
   PubMed Web of Science ®Google Scholar
• Hussain SK, Madeleine MM, Johnson LG, et al. Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer. 2013;133:201–213. doi:10.1002/ijc.28000
   PubMed Web of Science ®Google Scholar